The board of directors of Walgreen Co. (NYSE: WAG) (Nasdaq: WAG) today
declared a regular quarterly dividend of 27.5 cents per share, a 22.2
percent increase over the year ago dividend. The dividend is payable
June 12, 2013, to shareholders of record May 21, 2013.
Walgreens has paid a dividend in 322 straight quarters (more than 80
years) and has raised its dividend for 37 consecutive years. Over the
last five years, Walgreens annual dividend rate has increased from 38
cents per share to $1.10 per share, resulting in a compound annual
growth rate of nearly 24 percent.
About Walgreens
As the nation's largest drugstore chain with fiscal 2012 sales of $72
billion, Walgreens (www.walgreens.com)
vision is to become America’s first choice for health and daily living.
Each day, Walgreens provides more than 6 million customers the most
convenient, multichannel access to consumer goods and services and
trusted, cost-effective pharmacy, health and wellness services and
advice in communities across America. Walgreens scope of pharmacy
services includes retail, specialty, infusion, medical facility and mail
service, along with respiratory services. These services improve health
outcomes and lower costs for payers including employers, managed care
organizations, health systems, pharmacy benefit managers and the public
sector. The company operates 8,077 drugstores in all 50 states, the
District of Columbia and Puerto Rico. Take Care Health Systems is a
Walgreens subsidiary that is the largest and most comprehensive manager
of worksite health and wellness centers and in-store convenient care
clinics, with more than 700 locations throughout the country.
(Please note: Stock exchanges typically set the ex-dividend date two
business days before the shareholder-of-record date. This means if you
purchase stock on the ex-dividend date or after, you will not receive
the next dividend payment. If you purchase before the ex-dividend date,
you will receive the dividend.)
Statements in this release that are not historical are
forward-looking statements made pursuant to the safe harbor provisions
of the Private Securities Litigation Reform Act of 1995. These
forward-looking statements are not guarantees of future performance and
involve risks, assumptions and uncertainties, including those described
in Item 1A (Risk Factors) of our most recent Annual Report on Form 10-K
and Quarterly Report on Form 10-Q, as amended, each of which is
incorporated herein by reference and in other documents that we file or
furnish with the Securities and Exchange Commission. Should one or more
of these risks or uncertainties materialize, or should underlying
assumptions prove incorrect, actual results may vary materially from
those indicated or anticipated by such forward-looking statements.
Accordingly, you are cautioned not to place undue reliance on these
forward-looking statements, which speak only as of the date they are
made. Except to the extent required by law, Walgreens does not
undertake, and expressly disclaims, any duty or obligation to update
publicly any forward-looking statement after the distribution of this
release, whether as a result of new information, future events, changes
in assumptions or otherwise.
